On the other hand, low ERCC1 mRNA levels in primary gastric adenocarcinoma and lung cancer showed a positive association with improved survival of patients treated with cisplatin in combination with fluorouracil or gemcitabine 21,22. Here, ERCC1 is linked to gastric adenocarcinoma.